Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia.
Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC, USA.
Bruce D
BD
Cheson
John C
JC
Byrd
Kanti R
KR
Rai
Neil E
NE
Kay
Susan M
SM
O'Brien
Ian W
IW
Flinn
Adrian
A
Wiestner
Thomas J
TJ
Kipps
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors